2004

State biotech sector no miracle drug for creation of jobs “Ruth Scott’s job is to be the No. 1 cheerleader for biotechnology in Washington state. But when politicians talk up the industry as a silver bullet for job growth, she cringes.”

Big pharma’s pain could be biotech’s gain “Current problems besetting ‘big pharma’ could have a silver lining for the smaller biotechnology sector, some investors believe.”

The Waning Of The Blockbuster Drug “What’s promising now are drugs that target niche diseases. That means painful restructuring ahead for Big Pharma “

Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the market and losing a quarter of its stock market value as a result, Merck & Co. will try to dodge the storm clouds and turn its attention tomorrow to a brighter subject with the official [...]